Literature DB >> 27281297

Human Tuberculosis I. Epidemiology, Diagnosis and Pathogenetic Mechanisms.

Giampietro Sgaragli1, Maria Frosini.   

Abstract

Mycobacterium tuberculosis (M. tuberculosis), an almost genetically monomorphic pathogen is a human parasite, transmitted mostly by humans and causes tuberculosis (TB). TB is firmly associated to poverty, although lack of proper nutrition and lowered immune status are contributing factors for disease development. TB remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent and is responsible for nearly 1.5 million deaths annually. Some steps of the progress of our knowledge of M. tuberculosis physiology and its interactions with human beings, are reviewed here. This progress has provided fertile ground for improving diagnosis and cure of TB infection. For TB diagnostics laboratories in high-burden countries, primary isolation is the first step before performing drug susceptibility testing (DST) of M. tuberculosis. IGRA (interferon-γ release assay)-based tests for diagnosis of active TB are sufficiently fast, specific and sensitive to allow to contain infection and distinguish among latent TB infection and BCG vaccination individuals from those who have clinically resolved M. tuberculosis infection after anti-TB treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27281297     DOI: 10.2174/0929867323666160607222854

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Fabrication and Characterization of Optical Tissue Phantoms Containing Macrostructure.

Authors:  Madeleine S Durkee; Landon D Nash; Fatemeh Nooshabadi; Jeffrey D Cirillo; Duncan J Maitland; Kristen C Maitland
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

2.  Fluorescence modeling of in vivo optical detection of Mycobacterium tuberculosis.

Authors:  Madeleine S Durkee; Jeffrey D Cirillo; Kristen C Maitland
Journal:  Biomed Opt Express       Date:  2019-10-01       Impact factor: 3.732

3.  Application of the ARIMA Model in Forecasting the Incidence of Tuberculosis in Anhui During COVID-19 Pandemic from 2021 to 2022.

Authors:  Shuangshuang Chen; Xinqiang Wang; Jiawen Zhao; Yongzhong Zhang; Xiaohong Kan
Journal:  Infect Drug Resist       Date:  2022-07-04       Impact factor: 4.177

4.  Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.

Authors:  K Said; S Verver; A Kalingonji; F Lwilla; A Mkopi; S Charalambous; K Reither
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

5.  Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran.

Authors:  Amir Tajbakhsh; Faezeh Ghasemi; Seyedeh Zohre Mirbagheri; Mastoureh Momen Heravi; Mehdi Rezaee; Zahra Meshkat
Journal:  Iran J Pathol       Date:  2018-09-25

6.  Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses.

Authors:  Qiao Liu; Zhongqi Li; Ye Ji; Leonardo Martinez; Ui Haq Zia; Arshad Javaid; Wei Lu; Jianming Wang
Journal:  Infect Drug Resist       Date:  2019-07-26       Impact factor: 4.003

7.  Associations between genetic polymorphisms of TLRs and susceptibility to tuberculosis: A meta-analysis.

Authors:  Yong Zhou; Mengtao Zhang
Journal:  Innate Immun       Date:  2019-07-18       Impact factor: 2.680

8.  Functional variations of the TLR4 gene in association with chronic obstructive pulmonary disease and pulmonary tuberculosis.

Authors:  Zhongqi Li; Xuhua Mao; Qiao Liu; Huan Song; Biyu He; Peiyi Shi; Qun Zhang; Xiaona Li; Jianming Wang
Journal:  BMC Pulm Med       Date:  2019-10-22       Impact factor: 3.317

9.  Associations between vitamin D receptor genetic variants and tuberculosis: a meta-analysis.

Authors:  Xun Xu; Minghao Shen
Journal:  Innate Immun       Date:  2019-04-16       Impact factor: 2.680

10.  Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2 (DRAM2).

Authors:  Guangming Liu; Qiufeng Wan; Jingwen Li; Xinying Hu; Xingli Gu; Sicheng Xu
Journal:  Cell Cycle       Date:  2020-10-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.